Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Orpyx® logo — Diabetes Healthspan Extension

Orpyx®

Diabetes Healthspan Extension

Founded 2010 Canada Calgary, Canada 69 employees Series A Total: $16.30M Hardware, Health Care +2

General Information

Company Name Orpyx®
Founded Year 2010
Location Canada Calgary, Canada
Employees 69
Industries Hardware, Health Care, Health and Wellness +1
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Orpyx®. To contact Orpyx®, visit orpyx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Orpyx® compare?

A PDF of Orpyx® and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Orpyx® soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Orpyx®

Orpyx® is a leading digital therapeutics company committed to extending healthspan for people living with diabetes through personalized remote care. Their flagship product, the Orpyx® Sensory Insoles, is transforming diabetes care by helping prevent diabetic foot ulcers, a major complication that can lead to amputation. This Canadian-based company, founded in 2010, boasts a dedicated remote patient monitoring team comprised of credentialed providers and nurses. They utilize advanced data science methodologies to provide personalized support and triaged clinical escalation. With a whole-person approach, Orpyx empowers people to take control of their health, prevent debilitating complications, and extend their healthspan. In their latest funding round, Orpyx secured a $7.60M Series A investment on 08 July 2020. Key investors in this round include Anges Québec, Aphelion Capital, InterGen Capital, Thin Air Labs, Viewpoint, ICM Asset Management, Paddock Capital, Relentless Pursuit Partners, and Picante Capital. This impressive support from a diverse group of investors signifies the recognition of Orpyx's potential to make a significant impact in the health care industry. In summary, Orpyx is positioned at the forefront of utilizing digital therapeutics to enhance the lives of individuals with diabetes. Their innovative approach and recent substantial investment demonstrate their potential for long-term success in this crucial health care sector.

Business keywords: digital therapeutics, diabetes care, remote patient monitoring, data science, personalized care, patient empowerment, diabetic foot ulcers, chronic disease management, healthspan extension

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $7.60M 9
Anges Québec Aphelion Capital InterGen Capital
Anges Québec, Aphelion Capital +7
08 Jul 2020
Convertible Note $1.50M -
26 Oct 2018
Venture Round $5.00M -
27 Feb 2018
Non Equity Assistance Undisclosed 1
Creative Destruction Lab
Creative Destruction Lab
18 Oct 2017
Venture Round Undisclosed -
01 Jan 2017
Venture Round Undisclosed 1
VA Angels
VA Angels
01 Jan 2016
Seed Round $2.20M -
31 Dec 2013

Orpyx® Alternatives & Competitors

View All Alternatives
Orpyx® vs
Podimetrics
Podimetrics United States

Podimetrics helps patients, providers, and payers to prevent diabetic foot complications. Learn more...

Debt Financing
178 employees
Health Care, Medical Devices
Compare Orpyx® vs Podimetrics
Orpyx® vs
Otida
Otida Egypt

A HealthTech company offering an innovative and efficient care model for diabetic patients. We aim a...

Pre-Seed
8 employees
Health Care, Health and Wellness
Compare Orpyx® vs Otida
Orpyx® vs
Stēto
Stēto France

Creating continuous care in diabetes

Seed
12 employees
Health Care, Health and Wellness
Compare Orpyx® vs Stēto
Also compare with: Orpyx® vs Ascensia Diabetes Care Ascensia Diabetes Care View all alternatives

FAQ About Orpyx®

Diabetes Healthspan Extension
Orpyx® was founded in 2010.
Orpyx® is headquartered in Calgary, Canada.
Orpyx® operates in Hardware, Health Care, Health and Wellness and Medical Devices. Its work centres on digital therapeutics, diabetes care, remote patient monitoring and data science.
Orpyx® has approximately 69 employees.
Orpyx® has completed 7 funding rounds, raising a total of $16.30M. The latest funding stage is Series A.
Top alternatives and competitors to Orpyx® include Podimetrics, Otida, Stēto, Wellinks, Ryse Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Orpyx® and Podimetrics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Orpyx®, https://www.bouncewatch.com/company/orpyx, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout